Who
CHURCH KATRINA J
SVP & Chief Compliance Officer
Company insider
Files Form 4 as: SVP & Chief Compliance Officer, Bioventus; EVP Legal Affairs, GC & Secty, Connetics.
In numbers
- Trades disclosed
- 142
- Buys
- 1
- Sells
- 18
- Bought
- $33K
- Sold
- $699K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Feb 2006
- Last trade
- 10 Apr 2026
- Last filed
- 14 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Apr 2026filed 14 Apr 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —4,300 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code F | $17K1,868 at $9.06 | filing |
| 10 Apr 2026filed 14 Apr 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,300 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,300 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —4,300 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code F | $17K1,868 at $9.06 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —3,455 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code F | $13K1,501 at $8.62 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,455 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code F | $13K1,521 at $8.62 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —3,455 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code F | $13K1,501 at $8.62 | filing |
| 13 Mar 2026filed 17 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.